Korean J Gastroenterol.  2011 May;57(5):269-271. 10.4166/kjg.2011.57.5.269.

Clinical Characteristics and Risk Factors of Reflux Esophagitis: Comparison with Nonerosive Reflux Disease

• Moon W

• KMID: 1792782
• DOI: http://doi.org/10.4166/kjg.2011.57.5.269

Abstract

No abstract available.

MeSH Terms

Alcohol Drinking
Antacids/therapeutic use
Endoscopy, Gastrointestinal
Esophagitis, Peptic/complications/*diagnosis
Gastroesophageal Reflux/complications/*diagnosis
Humans
Risk Factors
Sex Factors

Reference

References

1. Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R. Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006; 101:1900–1920.

2. Klauser AG, Schindlbeck NE, Müller-Lissner SA. Symptoms in gastro-oesophageal reflux disease. Lancet. 1990; 335:205–208.

3. Nilsson M, Johnsen R, Ye W, Hveem K, Lagergren J. Prevalence of gastro-oesophageal reflux symptoms and the influence of age and sex. Scand J Gastroenterol. 2004; 39:1040–1045.

4. Fass R. Erosive esophagitis and nonerosive reflux disease (NERD): comparison of epidemiologic, physiologic, and therapeutic characteristics. J Clin Gastroenterol. 2007; 41:131–137.

5. DeVault KR. Review article: the role of acid suppression in patients with nonerosive reflux disease or functional heartburn. Aliment Pharmacol Ther. 2006; 23(Suppl 1):33–39.

6. Carlsson R, Dent J, Watts R, et al. Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. International GORD Study Group. Eur J Gastroenterol Hepatol. 1998; 10:119–124.

7. Dean BB, Gano AD Jr, Knight K, Ofman JJ, Fass R. Effectiveness of proton pump inhibitors in nonerosive reflux disease. Clin Gastroenterol Hepatol. 2004; 2:656–664.

8. Barlow WJ, Orlando RC. The pathogenesis of heartburn in non-erosive reflux disease: a unifying hypothesis. Gastroenterology. 2005; 128:771–778.

9. Lee SJ, Jung MK, Kim SK, et al. Clinical characteristics of gastroesophageal reflux disease with esophageal injury in Korean: focusing on risk factors. Korean J Gastroenterol. 2011; 57:281–287.

10. Kim N, Lee SW, Cho SI, et al. The prevalence of and risk factors for erosive oesophagitis and non-erosive reflux disease: a nationwide multicentre prospective study in Korea. Aliment Pharmacol Ther. 2008; 27:173–185.

11. Ha NR, Lee HL, Lee OY, et al. Differences in clinical characteristics between patients with non-erosive reflux disease and erosive esophagitis in Korea. J Korean Med Sci. 2010; 25:1318–1322.

12. Lee ES, Kim N, Lee SH, et al. Comparison of risk factors and clinical responses to proton pump inhibitors in patients with erosive oesophagitis and non-erosive reflux disease. Aliment Pharmacol Ther. 2009; 30:154–164.

13. Peng S, Xiong LS, Xiao YL, et al. Prompt upper endoscopy is an appropriate initial management in uninvestigated chinese patients with typical reflux symptoms. Am J Gastroenterol. 2010; 105:1947–1952.